• Abrdn plc: Morgan Stanley maintains its underweight/in-line recommendation with a target price reduced from GBX 177 to GBX 167.
  • American express: HSBC maintains its buy recommendation with a target price of USD 181.
  • Amgen inc: Goldman Sachs maintains its buy recommendation and reduces the target price from USD 310 to USD 305.
  • Ashmore group pl: Numis downgrades its recommendation to reduce with a price target reduced from GBX 175 to GBX 160.
  • Avangrid: Morningstar downgrades to hold from buy with a price target reduced from USD 38 to USD 33.
  • Biogen inc: Goldman Sachs maintains its buy recommendation and reduces the target price from USD 436 to USD 400.
  • Biomarin pharmac: Goldman Sachs maintains its buy recommendation and reduces the target price from USD 152 to USD 147.
  • Block: HSBC maintains its hold recommendation with a target price of USD 46.
  • British land: BNP Paribas Exane upgrades to outperform from neutral with a price target reduced from GBX 410 to GBX 370.
  • Capital one fina: HSBC maintains its reduce recommendation with a target price of USD 84.
  • Constellation en: Mizuho Securities maintains its neutral recommendation with a price target raised from USD 106 to USD 116.
  • Deliveroo plc: JP Morgan upgrades to neutral from underweight with a price target raised from GBP 1.13 to GBP 1.42.
  • Digital realty: DBS Bank maintains its buy recommendation with a target price of USD 149.15.
  • Discover financi: HSBC maintains its buy recommendation with a target price of USD 104.
  • Dollar general c: Gordon Haskett upgrades to buy from hold with a price target raised from USD 115 to USD 140.
  • Easyjet plc: Oddo BHF maintains its neutral recommendation with a price target reduced from GBP 5.60 to GBP 5.10.
  • Equinix: DBS Bank maintains its buy recommendation with a target price of USD 907.89.
  • Fortinet: Barclays downgrades to equalweight from overweight with a price target reduced from USD 71 to USD 63.
  • Hays plc: Liberum maintains its buy recommendation with a price target reduced from GBX 125 to GBX 120.
  • Jupiter fund: Morgan Stanley maintains its equal weight/in-line recommendation with a price target reduced from GBX 133 to GBX 115.
  • Man group: Morgan Stanley maintains its overweight/in-line recommendation with a target price raised from GBX 296 to GBX 307.
  • Mastercard: HSBC maintains its hold recommendation with a target price of USD 424.
  • Meta platforms: William O'Neil & Co Incorporated upgrades to buy from dropped coverage.
  • Moderna: Goldman Sachs maintains its buy recommendation with a target price reduced from USD 285 to USD 269.
  • Old dominion: Raymond James maintains its outperform rating and raises the target price from USD 440 to USD 455.
  • Paypal holdings: HSBC maintains its buy recommendation with a target price of USD 69.
  • Pioneer natural: Morningstar upgrades to buy from sell with a price target raised from USD 203 to USD 274.
  • Regeneron pharm: Goldman Sachs maintains its buy recommendation and raises the target price from USD 1028 to USD 1064.
  • Schroders plc: Morgan Stanley maintains its equalwt/in-line recommendation and reduces the target price from GBX 536 to GBX 515.
  • Synchrony financ: HSBC maintains its hold recommendation with a target price of USD 32.
  • Tractor supply: Oppenheimer downgrades to market perform from outperform with a price target reduced from USD 280 to USD 210.
  • Unilever plc: Bryan Garnier & Co. maintains its neutral recommendation with a price target raised from EUR 51 to EUR 54.
  • Union pac: Raymond James maintains its strong buy recommendation and reduces the target price from USD 270 to USD 240.
  • Vertex pharm: Goldman Sachs maintains its buy recommendation and reduces the target price from USD 437 to USD 436.
  • Visa: HSBC maintains its hold recommendation with a target price of USD 266.
  • Whitbread plc: Oddo BHF upgrades to outperform from neutral with a price target raised from GBP 35 to GBP 43.50.